This Study Tests How Healthy Men Tolerate Different Doses of BI1015550. The Study Also Tests How BI 1015550 is Taken up by the Body
Clinical trial NCT03230487 · COMPLETED
Trial details
- NCT number
- NCT03230487
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-10
- Primary completion
- 2018-01-16
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.